tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Pete Stavropoulos, 21 are a BUY (100%).
Analyst Pete Stavropoulos works at CANTOR FITZGERALD with a stock forecast success ratio of 26.67% fulfilled within 148.83 days on average.
Pete Stavropoulos’s has documented 42 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RZLT, Rezolute at 19-Sep-2023.
Analyst best performing recommendations are on ORTX (ORCHARD THERAPEUTICS PLC).
The best stock recommendation documented was for ORTX (ORCHARD THERAPEUTICS PLC) at 6/27/2023. The price target of $15 was fulfilled within 100 days with a profit of $9.77 (186.81%) receiving and performance score of 18.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
16
$11.45 (251.65%)
16
13 days ago
0/7 (0%)
$9.93 (163.59%)
Buy
13
$8.45 (185.71%)
11
23 days ago
1/4 (25%)
$6.37 (96.08%)
188
Buy
10
$5.45 (119.78%)
6
27 days ago
4/5 (80%)
$2.83 (39.47%)
106
Buy
30
$25.45 (559.34%)
30
28 days ago
0/3 (0%)
$22.19 (284.12%)
Buy
13
$8.45 (185.71%)
13
8 months 2 days ago
0/5 (0%)
$10.05 (340.68%)
What Year was the first public recommendation made by Pete Stavropoulos?
